FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer

By Yahoo! Finance | Aug 16, 2024 at 09:04 AM EST

The FDA approved AstraZeneca's Imfinzi in combination with chemo for early-stage non-small cell lung cancer. Imfinzi showed significant benefits in reducing recurrence and progression events. The drug is also under review for limited-stage small cell lung cancer.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.